Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BODI
BODI logo

BODI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Beachbody Company Inc (BODI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
10.880
1 Day change
-2.51%
52 Week Range
12.660
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Beachbody Company Inc (BODI) is not a strong buy at this time for a beginner investor with a long-term strategy. While the stock has bullish technical indicators and positive analyst ratings, the company's financial performance is weak with significant revenue and net income declines. Additionally, there are no recent positive news catalysts or significant trading trends to support immediate action.

Technical Analysis

The stock shows bullish technical indicators with MACD above 0 and positively contracting, RSI in the neutral zone at 63.948, and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 11.432, R1: 12.329, S1: 10.534, R2: 12.884, S2: 9.979.

Positive Catalysts

  • Analysts have raised price targets recently, with Canaccord increasing the target to $15 and maintaining a Buy rating. The company is launching new products and expanding its retail presence, which could drive future growth.

Neutral/Negative Catalysts

  • The company's financials for Q4 2025 show significant declines in revenue (-35.70% YoY), net income (-115.10% YoY), and EPS (-114.68% YoY). There are no recent news catalysts, and hedge funds and insiders are neutral with no significant trading trends.

Financial Performance

In Q4 2025, revenue dropped to $55.54M (-35.70% YoY), net income dropped to $5.22M (-115.10% YoY), and EPS fell to 0.74 (-114.68% YoY). However, gross margin improved to 74.45% (+5.63% YoY), indicating cost management improvements.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are optimistic, with Canaccord and Craig-Hallum maintaining Buy ratings and raising price targets to $15. They highlight the company's turnaround efforts and new product launches as positive factors.

Wall Street analysts forecast BODI stock price to rise
2 Analyst Rating
Wall Street analysts forecast BODI stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 11.160
sliders
Low
9
Averages
12
High
15
Current: 11.160
sliders
Low
9
Averages
12
High
15
Canaccord
Buy
maintain
$12 -> $15
AI Analysis
2026-03-11
Reason
Canaccord
Price Target
$12 -> $15
AI Analysis
2026-03-11
maintain
Buy
Reason
Canaccord raised the firm's price target on Beachbody Company to $15 from $12 and keeps a Buy rating on the shares. The firm updated its model following Q4 results which provided its ninth consecutive quarter of profitability highlighting management's plan is working.
Canaccord
Buy
maintain
$9 -> $12
2026-03-10
Reason
Canaccord
Price Target
$9 -> $12
2026-03-10
maintain
Buy
Reason
Canaccord raised the firm's price target on Beachbody Company to $12 from $9 and keeps a Buy rating on the shares. The firm raised its target as management continues to drive improved profitability of the overall business despite significant sales declines.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BODI
Unlock Now

People Also Watch